Januvia 50 mg Tablets contain Sitagliptin, an oral antidiabetic medicine classified as a DPP-4 (dipeptidyl peptidase-4) inhibitor. It works by enhancing incretin levels, which help increase insulin secretion and decrease glucagon levels in response to meals. Januvia is used to improve blood sugar control in adults with type 2 diabetes mellitus, often in combination with other antidiabetic agents such as metformin or sulfonylureas.

• Supports better post-meal and fasting blood sugar control

• Low risk of hypoglycemia when used alone

• Can be used in combination with other diabetes treatments

• Suitable for patients requiring dose adjustment (e.g., with renal impairment)

• Weight-neutral profile

• Take one tablet orally, once daily

• Can be taken with or without food

• Swallow the tablet whole with water

• Maintain consistent timing each day for optimal effect

• Recommended dose: 50 mg once daily, especially in patients with moderate renal impairment

• Your healthcare provider may adjust the dose based on kidney function and overall treatment plan

• Do not take more than the prescribed dose

• Not for use in type 1 diabetes or diabetic ketoacidosis

• Use with caution in individuals with a history of pancreatitis

• Kidney function should be monitored regularly, especially in elderly patients

• Inform your doctor if pregnant, breastfeeding, or planning pregnancy

• Common side effects:

• Stuffy or runny nose

• Sore throat

• Less common but serious side effects:

• Pancreatitis

• Joint pain

• Skin reactions

• Allergic reactions including rash, itching, or swelling

•  

• Headache

• Upper respiratory tract infection